-
Dr Lal PathLab hits record high; rises over 12% in three sessions
The stock has risen 12.33% in three sessions from its recent closing low of Rs 2,987.25 on 7 April 2021.
-
COVID-19 cases: Arvind Kejriwal warns of a possible lockdown in Delhi
Kejriwal said his government does not want to impose lockdown in Delhi, but such a situation may arise if there is a rush to hospitals and beds are unavailable for serious patients
-
Government may hike FDI limit in pension sector to 74%: Report
The amendment Bill may contain the separation of NPS Trust from the PFRDA
-
Buy on dip: IIFL Securities sees over 35% upside in this LIC’s latest stock pick
Brokerage firm IIFL Securities recently initiated the coverage on this PSU with a price target of Rs 2,174, indicating an upside of over 35% from the current market price
-
Nine items to help you travel safely in these Covid times
From anti-Covid keys to Oximeters, a look at items which will help you in executing your travel plans amid this surge in coronavirus cases
-
Covid second wave: How stock market investors are reacting to rising infections
Fitch Ratings has said the second wave of infections poses increased risks for India’s fragile economic recovery and its banks
-
DLF slips 8.48%, S&P BSE Realty index shed 6.73%
DLF Ltd has lost 17.06% over last one month compared to 11.6% fall in S&P BSE Realty Index index and 5.09% drop in the SENSEX
-
Anupam Rasayan repays significant debt from IPO proceeds
The repayment of debt will result in significant savings in the finance cost.
-
Stock market crash: Why Sensex tumbled over 1,400 points today
The 30-share BSE index traded 1,427 points lower at 48,164.32, while the broader NSE Nifty plunged 432 points to 14,402.95
-
Why Jubilant Pharmova shares rally over 6% in a weak market
The scrip traded 6.25% higher at Rs 782.50 at around 10 am (IST). On the other hand, the benchmark BSE Sensex was down 1,175 points, or 2.37%, at 48,415 at around the same time.
